Posted on

Oral Antivirals Could Transform the Treatment of COVID-19

external content.duckduckgo 31

the staff of the Ridgewood blog

Ridgewood NJ, Oral antivirals could transform the treatment of COVID-19, allowing some patients to take medicines while recovering at home instead of having to visit health clinics or be admitted to hospital to receive injections or infusions of currently available therapies. Pfizer this morning released final analysis of its oral antiviral candidate PAXLOVID (the protease inhibitors nirmatrelvir and ritonavir, taken together), showing the treatment retained its 89% efficacy in preventing hospitalization and death among 2,246 high-risk COVID-19 patients.

Continue reading Oral Antivirals Could Transform the Treatment of COVID-19

Posted on

Pfizer says Covid-19 Pill Close To 90% effective

external content.duckduckgo 30

the staff of the Ridgewood blog

NEW YORK NY, Pfizer Inc. (NYSE: PFE) today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) trial of its novel COVID-19 oral antiviral candidate PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets). These results were consistent with the interim analysis announced in November 2021, showing PAXLOVID significantly reduced the risk of hospitalization or death for any cause by 89% compared to placebo in non-hospitalized, high-risk adult patients with COVID-19 treated within three days of symptom onset. In a secondary endpoint, PAXLOVID reduced the risk of hospitalization or death for any cause by 88% compared to placebo in patients treated within five days of symptom onset, an increase from the 85% observed in the interim analysis. The EPIC-HR data have been shared with the U.S. Food and Drug Administration (FDA) as part of an ongoing rolling submission for Emergency Use Authorization (EUA).

Continue reading Pfizer says Covid-19 Pill Close To 90% effective

Posted on

Pfizer Requests Emergency Authorization for its Oral Antiviral Oral COVID-19 Treatment

Pfizer Logo

the staff of the Ridgewood blog

Ridgewood NJ, Pfizer requested emergency authorization for its antiviral oral COVID-19 treatment on Tuesday after a study found the pills dramatically reduced the risk of hospitalization.

Continue reading Pfizer Requests Emergency Authorization for its Oral Antiviral Oral COVID-19 Treatment